Pulse Biosciences Inc (PLSE)
NASDAQ
Closed
Oct 7, 2026
Day's Range
48.1352 wk Range
12.56Overview - PLSE - Pulse Biosciences Inc
Key Statistics
Valuation
Enterprise Value
3.32B
P/E (Trailing)
‪-44.29‬
P/E (Forward)
‪-40.94‬
PEG Ratio
‪-1.55‬
Price / Sales (TTM)
‪2,882.99‬
Price / Book
‪34.09‬
EV / EBITDA
‪-40.20‬
Profitability
Gross Margin
‪37.09%‬
Profit Margin
‪-54.00%‬
Operating Margin
‪-5,823.04%‬
Return on Assets
‪-44.33%‬
Return on Equity
‪-78.49%‬
Ownership
Shares Outstanding
70.79M
Float
20.64M
Short % of Shares Outstanding
‪14.72%‬
Held by Insiders
‪71.04%‬
Held by Institutions
‪15.39%‬
Price stats
Beta
‪1.62‬
50-Day Avg
‪46.55‬
200-Day Avg
‪27.56‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪$ 45.25‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PLSE - Pulse Biosciences Inc
Peers - PLSE - Pulse Biosciences Inc
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
- PLSENASDAQPulse Biosciences Inc3.41BMarket Cap+59.40%52-week change-44.30P/E (Trailing)‪-54.00%‬Profit Margin
- ISRGNASDAQIntuitive Surgical Inc.140.42BMarket Cap-14.73%52-week change45.00P/E (Trailing)‪28.44%‬Profit Margin
- MDLNNASDAQMedline Inc. Class A Common Stock47.91BMarket Cap-15.14%52-week change44.51P/E (Trailing)‪2.31%‬Profit Margin
- COONASDAQThe Cooper Companies, Inc.10.82BMarket Cap-23.20%52-week change19.56P/E (Trailing)‪13.46%‬Profit Margin
- ALGNNASDAQAlign Technology, Inc.10.42BMarket Cap+13.90%52-week change25.53P/E (Trailing)‪9.99%‬Profit Margin
- RGENNASDAQRepligen Corporation10.25BMarket Cap+17.39%52-week change248.90P/E (Trailing)‪5.29%‬Profit Margin
- MMEDNASDAQMiniMed Group, Inc.5.54BMarket Cap+6.14%52-week change-15.16P/E (Trailing)‪-9.74%‬Profit Margin
Profile Summary - PLSE - Pulse Biosciences Inc
About
Pulse Biosciences Inc is a bioelectric medicine company focused on developing and commercializing medical technologies that use proprietary pulsed-field energy to treat targeted cells while preserving surrounding tissue. Its current product portfolio includes the nPulse System for benign skin lesions, the nPulse…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
